Product previously referenced as HY-016, targeting genital and perianal warts US Commercialization by partner Padagis to start in December 2023 Second U.S. market approval of the year after Maxigesic® ...
Hyloris Pharmaceuticals SA's partner Padagis has received The Food and Drug Administration’s permission for Podofilox Gel, the first drug product generic to Condylox Gel 0.5%. For the 12 months period ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback